Market Place
Sourcing Support
All News #Library
Biotech
Hemab Therapeutics Announces Pricing of Upsized IPO
30 Apr 2026 //
GLOBENEWSWIRE
Novo-Backed Biotech Hemab Seeks To Raise $212 Million In US IPO
27 Apr 2026 //
BLOOMBERG
Seaport, Hemab Prepare Ipos To Fund Depression, Clotting Drugs
13 Apr 2026 //
FIERCE BIOTECH
Hemab Pharma Granted FDA Breakthrough Status For Sutacimig
05 Mar 2026 //
PR NEWSWIRE
Hemab Therapeutics Advances Sutacimig For Glanzmann
09 Dec 2025 //
PR NEWSWIRE
Hemab Therapeutics Secures $157M For Bleeding Disorder Treatments
27 Oct 2025 //
PR NEWSWIRE
Hemab Therapeutics Names Anant Murthy, PhD, Chief Operating
02 Sep 2025 //
PR NEWSWIRE
Hemab Therapeutics Presents Positive Data at ISTH 2025 Congress
24 Jun 2025 //
PR NEWSWIRE
Hemab Therapeutics to Present Data at ISTH 2025 Congress
10 Jun 2025 //
PR NEWSWIRE
Hemab Announces First Patient Dosed in Phase 2 Study Investigating HMB-001
11 Dec 2023 //
PR NEWSWIRE
Rare blood disorders biotech Hemab raises $135M, begins trek into clinic
20 Feb 2023 //
ENDPTS
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.